These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1696081)

  • 21. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
    Geraghty DP; Mussap CJ; Burcher E
    Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance P: a late-acting B lymphocyte differentiation cofactor.
    Bost KL; Pascual DW
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C537-45. PubMed ID: 1372476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptides and immunity.
    Stanisz A; Scicchitano R; Stead R; Matsuda H; Tomioka M; Denburg J; Bienenstock J
    Am Rev Respir Dis; 1987 Dec; 136(6 Pt 2):S48-51. PubMed ID: 2446542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production.
    Pascual DW; Xu-Amano JC; Kiyono H; McGhee JR; Bost KL
    J Immunol; 1991 Apr; 146(7):2130-6. PubMed ID: 1706387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism.
    Kavelaars A; Jeurissen F; von Frijtag Drabbe Künzel J; Herman van Roijen J; Rijkers GT; Heijnen CJ
    J Neuroimmunol; 1993 Jan; 42(1):61-70. PubMed ID: 7678598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of neurokinin receptors.
    Regoli D; Nantel F
    Biopolymers; 1991 May; 31(6):777-83. PubMed ID: 1718474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease.
    Mantyh CR; Gates TS; Zimmerman RP; Welton ML; Passaro EP; Vigna SR; Maggio JE; Kruger L; Mantyh PW
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3235-9. PubMed ID: 2834738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation.
    Takeda Y; Krause JE
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):392-6. PubMed ID: 2463627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses.
    Brodbeck RM; Sachais BS; Krause JE
    Mol Pharmacol; 1995 May; 47(5):1065-71. PubMed ID: 7538194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function.
    Quinlan KL; Song IS; Bunnett NW; Letran E; Steinhoff M; Harten B; Olerud JE; Armstrong CA; Wright Caughman S; Ansel JC
    Am J Physiol; 1998 Dec; 275(6):C1580-90. PubMed ID: 9843720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation.
    Wu H; Guan C; Qin X; Xiang Y; Qi M; Luo Z; Zhang C
    Pulm Pharmacol Ther; 2007; 20(5):513-24. PubMed ID: 16777450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus.
    Mussap CJ; Burcher E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1043-53. PubMed ID: 8394903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Substance P and human skin].
    Staniek V; Misery L
    Pathol Biol (Paris); 1996 Dec; 44(10):860-6. PubMed ID: 9157365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of substance P binding to human monocytes/macrophages.
    Lucey DR; Novak JM; Polonis VR; Liu Y; Gartner S
    Clin Diagn Lab Immunol; 1994 May; 1(3):330-5. PubMed ID: 7496971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
    Palma C; Nardelli F; Manzini S; Maggi CA
    Br J Cancer; 1999 Jan; 79(2):236-43. PubMed ID: 9888463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two classes of binding sites for [3H]substance P in rat cerebral cortex.
    Geraghty DP; Burcher E
    Brain Res; 1993 Jan; 601(1-2):34-40. PubMed ID: 7679311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors.
    Brunelleschi S; Vanni L; Ledda F; Giotti A; Maggi CA; Fantozzi R
    Br J Pharmacol; 1990 Jul; 100(3):417-20. PubMed ID: 1697194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance P actions on sensory neurons.
    Spigelman I; Puil E
    Ann N Y Acad Sci; 1991; 632():220-8. PubMed ID: 1719868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS.
    Bost KL; Breeding SA; Pascual DW
    Reg Immunol; 1992; 4(2):105-12. PubMed ID: 1380279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.